The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 3072-3080

  Wang, Liying ^a   Azad, Neelam ^b   Kongkaneramit, Lalana ^b   Chen, Fei ^a   Lu, Yongju ^b   Jiang, Bing Hua ^b   Rojanasakul, Yon ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; FLICE INHIBITORY PROTEIN; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; NITRIC OXIDE; PROTEASOME; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER; SUPEROXIDE DISMUTASE; CASPASE; FAS ANTIGEN; FASL PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME DEGRADATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG ALVEOLUS EPITHELIUM; MALE; MOLECULAR INTERACTION; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TARGET CELL; UBIQUITINATION; ANIMAL; CELL CULTURE; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGY; LUNG; METABOLISM; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CELL DEATH; CELLS, CULTURED; DOWN-REGULATION; FAS LIGAND PROTEIN; HUMANS; LUNG; MALE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION;

EID: 49149130029     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.3072     Document Type: Article

References (59)

1. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267: 1449-1456.
2. Nagata, S. 1997. Apoptosis by death factor. Cell 88: 355-365.
3. Lenardo, M., K. M. Chan, F. Hornung, H. McFarland, R. Siegel, J. Wang, and L. Zheng. 1999. Mature T lymphocyte apoptosis: immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17: 221-253.
4. Nagata, S. 1999. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33: 29-55.
5. Hsu, H. C., Y. Matsuki, H. G. Zhang, T. Zhou, and J. D. Mountz. 2001. The Fas signaling connection between autoimmunity and embryonic lethality. J. Clin. Immunol. 21: 1-14.
6. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976.
7. Chervonsky, A. V., Y. Wang, F. S. Wong, I. Visintin, R. A. Flavell, C. A. Janeway, Jr., and L. A. Matis. 1997. The role of Fas in autoimmune diabetes. Cell 89: 17-24.
8. Kuwano, K., N. Hagimoto, M. Kawasaki, T. Yatomi, N. Nakamura, S. Nagata, T. Suda, R. Kentaku, T. Maeyama, H. Miyazaki, and N. Hara. 1999. Essential roles of the Fas-Fas-ligand pathway in pulmonary fibrosis. J. Clin. Invest. 104: 13-19.
9. Matute-Bello, G., R. K. Winn, M. Jonas, E. Y. Chi, T. R. Martin, and W. C. Liles. 2001. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am. J. Pathol. 158: 153-161.
10. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497-500.
11. Friesen, C., I. Herr, P. H. Krammer, and K. M. Debatin. 1996. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2: 574-577.
12. Muller, M., S. Strand, H. Hug, E. M. Heinemann, H. Walczak, W. J. Hofmann, W. Stremmel, P. H. Krammer, and P. R. Galle. 1997. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99: 403-413.
13. Rehemtulla, A., C. A. Hamilton, A. M. Chinnaiyan, and V. M. Dixit. 1997. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/ APO-1). J. Biol. Chem. 272: 25783-25786.
14. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195.
15. Tschopp, J., M. Irmler, and M. Thome. 1998. Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10: 552-558.
16. Krueger, A., S. Baumann, P. H. Krammer, and S. Kirchhoff. 2001. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell. Biol. 21: 8247-8254.
17. L is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21: 3704-3714.
18. Siegel, R. M., D. A. Martin, L. Zheng, S. Y. Ng, J. Bertin, J. Cohen, and M. J. Lenardo. 1998. Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis. J. Cell Biol. 141: 1243-1253.
19. Vercammen, D., G. Brouckaert, G. Denecker, M. Van den Craen, W. Declercq, W. Fiers, and P. Vandenabeele. 1998. Dual signaling of the Fas receptor: inhibition of both apoptotic and necrotic pathways. J. Exp. Med. 188: 919-930.
20. -synthesis. Immunology 89: 205-212.
21. Sato, T., T. Machida, S. Takahashi, S. Iyama, Y. Sato, K. Kuribayashi, K. Takada, T. Oku, Y. Kawano, et al. 2004. Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J. Immunol. 173: 285-296.
22. Medan, D., L. Wang, D. Toledo, B. Lu, C. Stehlik, X. Shi, and Y. Rojanasakul. 2005. Regulation of Fas (CD95/APO-1)-mediated apoptosis and necrosis by reactive oxygen species in macrophages. J. Cell. Physiol. 203: 78-84.
23. Hug, H., M. Enari, and S. Nagata. 1994. No requirement of reactive oxygen intermediates in Fas-mediated apoptosis. FEBS Lett. 351: 311-313.
24. Wang, L., D. Toledo-Velasquez, D. Schwegler-Berry, J. K. H. Ma, and Y. Rojanasakul. 1993. Transport and hydrolysis of enkephalins in cultured alveolar epithelial monolayers. Pharm. Res. 10: 1662-1667.
25. Salvesen, G. S., and V. M. Dixit. 1997. Caspases: intracellular signaling by proteolysis. Cell 91: 443-446.
26. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17: 331-367.
27. Freeman, B., and J. Crapo. 1982. Biology of disease: free radicals and tissue injury. Lab. Invest. 47: 412-426.
28. Irani, K., Y. Xia, J. L. Zweier, S. J. Sollott, C. J. Der, E. R. Fearon, M. Sundaresan, T. Finkel, and P. J. Goldschmidt-Clermont. 1997. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652.
29. Chen, Q., E. J. Vazquez, S. Moghaddas, C. L. Hoppel, and E. J. Lesnefsky. 2003. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 278: 36027-36031.
30. Sakon, S., X. Xue, M. Takekawa, T. Sasazuki, T. Okazaki, Y. Kojima, J. H. Piao, H. Yagita, K. Okumura, T. Doi, and H. Nakano. 2003. NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22: 3898-3909.
31. Sulciner, D. J., K. Irani, Z. X. Yu, V. J. Ferrans, P. Goldschmidt-Claermont, and T. Finkel. 1996. Rac1 regulates a cytokine-stimulated redox-dependent pathway necessary for NF-κB activation. Mol. Cell. Biol. 16: 7115-7121.
32. Sulciner, D. J., Z. X. Yu, V. J. Ferrans, K. Gutkindm, K. Irani, P. Goldschmidt-Clermont, and T. Finkel. 1996. Rac1 regulates reactive oxygen species generation in fibroblasts. Biochem. J. 318: 379-382.
33. Deshpande, S. S., P. Angkeow, J. Huang, M. Ozaki, and K. Irani. 2000. Rac1 inhibits TNF-α-induced endothelial cell apoptosis: dual regulation by reactive oxygen species. FASEB J. 14: 1705-1714.
34. Kim, Y., N. Suh, M. Sporn, and J. C. Reed. 2002. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J. Biol. Chem. 277: 22320-22329.
35. Perez, D., and E. White. 2003. E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIPs. J. Virol. 77: 2651-2662.
36. Poukkula, M., A. Kaunisto, V. Hietakangas, K. Denessiouk, T. Katajamaki, M. S. Johnson, L. Sistonen, and J. E. Eriksson. 2005. Rapid turnover of c-FLIP-short is determined by its unique C-terminal tail. J. Biol. Chem. 280: 27345-27355.
37. Chanvorachote, P., U. Nimmannit, L. Wang, C. Stehlik, B. Lu, N. Azad, and Y. Rojanasakul. 2005. Nitric oxide negatively regulates Fas (CD95)-induced apoptosis through inhibition of ubiquitin-proteasome mediated degradation of FLIP. J. Biol. Chem. 280: 42044-42050.
38. Borutaite, V., and G. C. Brown. 2003. Nitric oxide induces apoptosis via hydrogen peroxide, but necrosis via energy and thiol depletion. Free Radical Biol. Med. 35: 1457-1468.
39. Wenzel, U., S. Kuntz, U. J. De Sousa, and H. Daniel. 2003. Nitric oxide suppresses apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Int. J. Cancer 106: 666-675.
40. Conde de la Rosa, L., M. H. Schoemaker, T. E. Vrenken, M. Buist-Homan, R. Havinga, P. L. Jansen, and H. Moshage. 2005. Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases. J. Hepatol. 44: 918-929.
41. Malassagne, B., P. J. Ferret, R. Hammoud, M. Tulliez, S. Bedda, H. Trébéden, P. Jaffray, Y. Calmus, B. Weill, and F. Batteux. 2001. The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse. Gastroenterology 121: 1451-1459.
42. Rayner, B. S., T. T. Duong, S. J. Myers, and P. K. Witting. 2006. Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury. J. Neurochem. 97: 211-221.
43. Aronis, A., J. Andr's Melendez, O. Golan, S. Shilo, N. Dicter, and O. Tirosh. 2003. Potentiation of Fas-mediated apoptosis by attenuated production of mitochondria-derived reactive oxygen species. Cell Death Differ. 10: 335-344.
44. Pham, C. G., C. Bubici, F. Zazzeroni, S. Papa, J. Jones, K. Alvarez, S. Jayawardena, E. De Smaele, R. Cong, C. Beaumont, et al. 2004. Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 119: 529-542.
45. Kamata, H., S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin. 2005. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661.
46. Ventura, J. J., P. Cogswell, R. A. Flavell, A. S. Baldwin, Jr., and R. J. Davis. 2004. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev. 18: 2905-2915.
47. L, directly binds to MKK7 and inhibits the JNK pathway. EMBO J. 25: 5549-5559.
48. Kataoka, T., R. C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, and J. Tschopp. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10: 640-648.
49. 2 terminus (p22-FLIP) induces NF-κB activation. J. Exp. Med. 203: 1295-1305.
50. Bokoch, G. M. 1994. Regulation of the human neutrophil NADPH oxidase by the Rac GTP-binding proteins. Curr. Opin. Cell Biol. 6: 212-218.
51. Gulbins, E., R. Bissonette, A. Mahboubi, W. Nishioka, T. Brunner, G. Baier, G. Baier-Bitterlich, C. Byrd, F. Lang, R. Kolesnick, et al. 1995. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2: 341-351.
52. Korkolopoulou, P., A. Goudopoulou, G. Voutsinas, E. P. Kapralos, E. Patsouris, and A. A. Saetta. 2004. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations. Urology 63: 1198-1204.
53. Sharp, D. A., D. A. Lawrence, and A. Ashkenazi. 2005. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptormediated caspase-8 activation and apoptosis. J. Biol. Chem. 280: 19401-19409.
54. Tanaka, T., M. Yoshimi, T. Maeyama, N. Hagimoto, K. Kuwano, and N. Hara. 2002. Resistance to Fas-mediated apoptosis in human lung fibroblast. Eur. Respir. J. 20: 359-368.
55. Medema, J. P., J. de Jong, T. van Hall, C. J. Melief, and R. Offringa. 1999. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J. Exp. Med. 190: 1033-1038.
56. Kinoshita, H., H. Yoshikawa, K. Shiki, Y. Hamada, Y. Nakajima, and K. Tasaka. 2000. Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression. Int. J. Cancer 88: 986-991.
57. Watanabe, K., K. Okamoto, and S. Yonehara. 2005. Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP. Cell Death Differ. 12: 10-18.
58. Day, T. W., F. Najafi, C.-H. Wu, and A. R. Safa. 2006. Cellular FLICE-like inhibitory protein (c-FLIP): a novel target for Taxol-induced apoptosis. Biochem. Pharmacol. 71: 1551-1561.
59. Rogers, K. M. A., M. Thomas, L. Galligan, T. R. Wilson, W. L. Allen, H. Sakai, P. G. Johnston, and D. B. Longley. 2007. Cellular FLICE-inhibitory protein regulates chemotherapy-induced apoptosis in breast cancer cells. Mol. Cancer Ther. 6: 1544-1551.